In an adult with chronic liver disease, can serum ammonia alone grade hepatic encephalopathy, and which clinical scoring system should be used?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 1, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Serum Ammonia Cannot Grade Hepatic Encephalopathy: Use Clinical Scoring Systems

Serum ammonia levels alone do not add any diagnostic, staging, or prognostic value for grading hepatic encephalopathy in patients with chronic liver disease, and you should instead use the West Haven Criteria (WHC) or Glasgow Coma Scale (GCS) for clinical grading. 1

Why Ammonia Fails as a Grading Tool

The 2014 AASLD/EASL joint practice guidelines explicitly state that elevated blood ammonia does not correlate reliably with hepatic encephalopathy severity or grade. 1 While ammonia is mechanistically important in the pathophysiology of hepatic encephalopathy, the relationship between ammonia levels and clinical severity is non-linear and unpredictable. 2

Key limitations of ammonia for grading:

  • Ammonia may remain elevated in cirrhotic patients without any encephalopathy symptoms 3
  • Ammonia can stay elevated even after clinical resolution of hepatic encephalopathy 2
  • Technical challenges with specimen handling frequently produce falsely elevated results 1

The Single Valid Use of Ammonia: Ruling Out Hepatic Encephalopathy

A normal ammonia level has high negative predictive value and should prompt immediate investigation for alternative causes of altered mental status. 2, 3 If you check an ammonia level in a patient with suspected overt hepatic encephalopathy and it returns normal, the diagnosis of hepatic encephalopathy is in question and you must search for other etiologies including:

  • Intracranial hemorrhage (5-fold increased risk in cirrhosis) 1
  • Septic encephalopathy 2
  • Hyponatremia 2
  • Wernicke's encephalopathy 2
  • Medication effects 2, 3
  • Alcohol withdrawal 3

Recommended Clinical Scoring Systems

Overt hepatic encephalopathy should be graded using the West Haven Criteria (WHC) or Glasgow Coma Scale (GCS), both validated clinical tools. 1

West Haven Criteria for Grading:

  • Grade I: Trivial lack of awareness, shortened attention span, impaired addition/subtraction
  • Grade II: Lethargy, disorientation to time, personality change, inappropriate behavior
  • Grade III: Somnolence to semi-stupor, responsive to stimuli, confused, gross disorientation
  • Grade IV: Coma, unresponsive to painful stimuli

These grades reflect the degree of self-sufficiency and need for care, which directly impacts patient morbidity and quality of life. 1

For Minimal/Covert Hepatic Encephalopathy:

Use validated psychometric and neurophysiological testing, not ammonia levels. 1 The guidelines recommend at least two validated testing strategies:

  • Paper-pencil tests (PHES - Psychometric Hepatic Encephalopathy Score) 1
  • Computerized tests (CRT, ICT, SCAN, or Stroop) 1
  • Neurophysiological tests (Critical Flicker Frequency or EEG) 1

When Repeated Ammonia Measurements May Be Justified

Repeated ammonia measurements are only appropriate in research settings to assess the efficacy of ammonia-lowering drugs, not for routine clinical management. 2, 3 Serial ammonia values should not guide your therapeutic decisions or determine when to escalate or de-escalate treatment. 2

Critical Pitfall to Avoid

Do not delay empirical treatment while waiting for ammonia results. 2 Hepatic encephalopathy is a clinical diagnosis requiring immediate therapy with lactulose (titrated to 2-3 soft bowel movements daily), regardless of ammonia level. 2 The dose adjustment should be based on clinical response and stool frequency, not ammonia values. 2

Special Context: Acute Liver Failure

The one exception where ammonia has prognostic value is in acute liver failure (distinct from chronic liver disease), where arterial ammonia levels >200 µg/dL predict increased risk of cerebral edema and intracranial hypertension. 2, 4 This does not apply to the chronic liver disease population where ammonia monitoring has no clinical role. 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Serum Ammonia and Hepatic Encephalopathy Diagnosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Ammonia Measurement in Hepatic Encephalopathy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Dialysis in Hepatic Encephalopathy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.